Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Update

Vyome Holdings, Inc. (NASDAQ:HIND) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 149,400 shares, a decrease of 26.9% from the September 30th total of 204,300 shares. Based on an average trading volume of 542,200 shares, the days-to-cover ratio is currently 0.3 days. Currently, 2.7% of the company’s stock are sold short. Currently, 2.7% of the company’s stock are sold short. Based on an average trading volume of 542,200 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HIND. Wall Street Zen raised Vyome from a “sell” rating to a “hold” rating in a research report on Thursday, October 9th. Citigroup raised Vyome to a “buy” rating in a report on Thursday, October 2nd. Finally, Maxim Group reissued a “buy” rating and issued a $15.00 target price on shares of Vyome in a report on Thursday, October 2nd. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Vyome presently has an average rating of “Buy” and an average target price of $15.00.

Vyome Stock Performance

Shares of HIND stock traded up $0.26 during mid-day trading on Monday, hitting $6.31. 175,318 shares of the stock were exchanged, compared to its average volume of 412,356. The firm has a market cap of $23.09 million, a price-to-earnings ratio of -0.01 and a beta of 1.15. Vyome has a 12-month low of $4.71 and a 12-month high of $690.33.

Vyome Company Profile

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.